Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies
R. K. Malladi; A. J. Peniket; A. E. Norton; A. J. Campbell; G. P. Collins; J. Samol; H. Eagleton; E. Miller; G. Morgenstern; J. Jones; A. Keen-Mcguire; M. Barnardo; T. J. Littlewood
- 作者R. K. Malladi; A. J. Peniket; A. E. Norton; A. J. Campbell; G. P. Collins; J. Samol; H. Eagleton; E. Miller; G. Morgenstern; J. Jones; A. Keen-Mcguire; M. Barnardo; T. J. Littlewood
- 卷第73卷
- 期第2期
- 印刷ISSN0902-4441
- 电子ISSN1600-0609
- 文件大小127.09KB
- 发表时间2004
- DOI10.1111/j.1600-0609.2004.00266.x
- 页码85-92